Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) have earned a consensus rating of "Buy" from the six analysts that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has assigned a

marketbeat.com

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Rating of "Buy" by Brokerages

Media Bias/Fact Check

Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus rating of “Buy” by the seven brokerages that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the stock in the […]

reporter.am

Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Recommendation of “Buy” by Brokerages

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) have been given an average rating of “Buy” by the five analysts that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 […]

watchlistnews.com

Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of “Buy” by Brokerages

Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have been assigned an average recommendation of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong […]

com-unik.info

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Average Recommendation of “Buy” by Brokerages

Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) have earned a consensus rating of “Buy” from the six analysts that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […]

ETF Daily News

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Rating of “Buy” by Brokerages

Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year […]

americanbankingnews.com

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Consensus Recommendation of “Buy” by Analysts

Astria Therapeutics (NASDAQ:ATXS – Get Free Report) and RedHill Biopharma (NASDAQ:RDHL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings. Institutional and Insider Ownership 99.0% of Astria Therapeutics shares are held by institutional in…

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Rating of "Buy" by Brokerages

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics